Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 12/2009

01.12.2009 | Article

Hemolytic uremic syndrome (HUS)—incidence and etiologies at a regional Children’s Hospital in 2001–2006

verfasst von: R. J. Pomajzl, M. Varman, A. Holst, A. Chen

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Hemolytic uremic syndrome (HUS) is a serious health concern in children. HUS has primarily been linked to Escherichia coli O157:H7 infections, but non-O157 strains are gaining attention. Hemolytic anemia, thrombocytopenia, and acute renal failure are the characteristics of the syndrome. This study investigated the incidence of HUS at a regional Children’s Hospital between 2001 and 2006 by retrospective review. Cases of HUS were investigated for outcomes based on stool culture and an association of acute pancreatitis. A total of 44 cases were identified, of which 57% were female and 43% were male, with an age distribution of 13 months to 17 years and a median age of 3.44 years. Data revealed 13 cases in 2006 compared to two cases in 2001, with 84% of all illnesses occurring in the summer and fall seasons. The median duration of thrombocytopenia was eight days and 50% of all cases required dialysis. E. coli O157:H7 was the predominant pathogen; however, 53% of the cases had unknown etiology. This data may suggest a growing number of cases from 2001 to 2006 and a role for agents other than E. coli O157:H7. E. coli O157:H7 caused longer intensive care unit (ICU) stay. No association between HUS and acute pancreatitis was found.
Literatur
1.
Zurück zum Zitat Banatvala N, Griffin PM, Greene KD et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed Banatvala N, Griffin PM, Greene KD et al (2001) The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183:1063–1070CrossRefPubMed
2.
Zurück zum Zitat Friedrich AW, Zhang W, Bielaszewska M et al (2007) Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45:39–45CrossRefPubMed Friedrich AW, Zhang W, Bielaszewska M et al (2007) Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis 45:39–45CrossRefPubMed
3.
Zurück zum Zitat Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74:991–996PubMed Razzaq S (2006) Hemolytic uremic syndrome: an emerging health risk. Am Fam Physician 74:991–996PubMed
4.
Zurück zum Zitat Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364–368CrossRefPubMed Boyce TG, Swerdlow DL, Griffin PM (1995) Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364–368CrossRefPubMed
5.
Zurück zum Zitat Geelen JM, van der Velden TJ, van den Heuvel LP et al (2007) Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 22:1181–1187CrossRefPubMed Geelen JM, van der Velden TJ, van den Heuvel LP et al (2007) Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 22:1181–1187CrossRefPubMed
6.
Zurück zum Zitat Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRefPubMed
7.
Zurück zum Zitat Chaisri U, Nagata M, Kurazono H et al (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31:59–67CrossRefPubMed Chaisri U, Nagata M, Kurazono H et al (2001) Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome. Microb Pathog 31:59–67CrossRefPubMed
8.
Zurück zum Zitat Wickham ME, Lupp C, Mascarenhas M et al (2006) Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194:819–827CrossRefPubMed Wickham ME, Lupp C, Mascarenhas M et al (2006) Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 194:819–827CrossRefPubMed
9.
Zurück zum Zitat Brooks JT, Sowers EG, Wells JG et al (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192:1422–1429CrossRefPubMed Brooks JT, Sowers EG, Wells JG et al (2005) Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983–2002. J Infect Dis 192:1422–1429CrossRefPubMed
10.
Zurück zum Zitat Johnson KE, Thorpe CM, Sears CL (2006) The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43:1587–1595CrossRefPubMed Johnson KE, Thorpe CM, Sears CL (2006) The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 43:1587–1595CrossRefPubMed
11.
Zurück zum Zitat Mead PS, Slutsker L, Dietz V et al (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607–625CrossRefPubMed Mead PS, Slutsker L, Dietz V et al (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607–625CrossRefPubMed
12.
Zurück zum Zitat Sass DA, Chopra KB, Regueiro MD (2003) Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome. Dig Dis Sci 48:415–416CrossRefPubMed Sass DA, Chopra KB, Regueiro MD (2003) Pancreatitis and E. coli O157:H7 colitis without hemolytic uremic syndrome. Dig Dis Sci 48:415–416CrossRefPubMed
13.
Zurück zum Zitat Brandt JR, Joseph MW, Fouser LS et al (1998) Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12:222–225CrossRefPubMed Brandt JR, Joseph MW, Fouser LS et al (1998) Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12:222–225CrossRefPubMed
14.
Zurück zum Zitat Grodinsky S, Telmesani A, Robson WL et al (1990) Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 11:518–524PubMedCrossRef Grodinsky S, Telmesani A, Robson WL et al (1990) Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis. J Pediatr Gastroenterol Nutr 11:518–524PubMedCrossRef
15.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2006) Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach—United States, September 2006. MMWR Morb Mortal Wkly Rep 55:1045–1046 Centers for Disease Control and Prevention (CDC) (2006) Ongoing multistate outbreak of Escherichia coli serotype O157:H7 infections associated with consumption of fresh spinach—United States, September 2006. MMWR Morb Mortal Wkly Rep 55:1045–1046
16.
Zurück zum Zitat Joishy M, Jauhari P, Mathew AA et al (2008) Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection? Arch Dis Child 93:180–181CrossRefPubMed Joishy M, Jauhari P, Mathew AA et al (2008) Can we predict the development of haemolytic uraemic syndrome in the early stage of Escherichia coli O157 infection? Arch Dis Child 93:180–181CrossRefPubMed
17.
Zurück zum Zitat Kandula L, Lowe ME (2008) Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 152:106–110CrossRefPubMed Kandula L, Lowe ME (2008) Etiology and outcome of acute pancreatitis in infants and toddlers. J Pediatr 152:106–110CrossRefPubMed
18.
Zurück zum Zitat Hogan MC, Gloor JM, Uhl JR et al (2001) Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis 38:E22CrossRefPubMed Hogan MC, Gloor JM, Uhl JR et al (2001) Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis 38:E22CrossRefPubMed
19.
Zurück zum Zitat Waters AM, Kerecuk L, Luk D et al (2007) Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 151:140–144CrossRefPubMed Waters AM, Kerecuk L, Luk D et al (2007) Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 151:140–144CrossRefPubMed
20.
Zurück zum Zitat Oakes RS, Siegler RL, McReynolds MA et al (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117:1656–1662CrossRefPubMed Oakes RS, Siegler RL, McReynolds MA et al (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117:1656–1662CrossRefPubMed
21.
Zurück zum Zitat Ahmed A, Li J, Shiloach Y et al (2006) Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2–5-year-old children. J Infect Dis 193:515–521CrossRefPubMed Ahmed A, Li J, Shiloach Y et al (2006) Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2–5-year-old children. J Infect Dis 193:515–521CrossRefPubMed
22.
Zurück zum Zitat Fey PD, Wickert RS, Rupp ME et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533CrossRefPubMed Fey PD, Wickert RS, Rupp ME et al (2000) Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6:530–533CrossRefPubMed
Metadaten
Titel
Hemolytic uremic syndrome (HUS)—incidence and etiologies at a regional Children’s Hospital in 2001–2006
verfasst von
R. J. Pomajzl
M. Varman
A. Holst
A. Chen
Publikationsdatum
01.12.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0800-y

Weitere Artikel der Ausgabe 12/2009

European Journal of Clinical Microbiology & Infectious Diseases 12/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.